Trademark: 88574343
Status Date
Monday, July 13, 2020
Filing Date
Sunday, August 11, 2019
Published for Opposition
Tuesday, December 31, 2019
44 Medical treatment services, namely, customized therapies using combinations of naltrexone, bioidentical hormones, and peptides for optimizing metabolic function to enable the body's natural anabolic processes to enhance body composition
Jul 14, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 13, 2020
Allowed Principal Register - Sou Accepted
Jun 18, 2020
Statement Of Use Processing Complete
May 28, 2020
Use Amendment Filed
Jun 18, 2020
Case Assigned To Intent To Use Paralegal
May 28, 2020
Teas Statement Of Use Received
Feb 25, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 31, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 31, 2019
Published For Opposition
Dec 11, 2019
Notification Of Notice Of Publication E-Mailed
Nov 23, 2019
Approved For Pub - Principal Register
Nov 22, 2019
Teas/Email Correspondence Entered
Nov 22, 2019
Correspondence Received In Law Office
Nov 22, 2019
Teas Response To Office Action Received
Nov 16, 2019
Notification Of Non-Final Action E-Mailed
Nov 16, 2019
Non-Final Action E-Mailed
Nov 16, 2019
Non-Final Action Written
Nov 8, 2019
Assigned To Examiner
Aug 27, 2019
New Application Office Supplied Data Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
